IL6R and rheumatoid arthritis: Supporting the pathological role of JAK in RA, a recent GWAS study revealed a significant association between polymorphisms in the genes of the JAK-STAT signaling pathway (TYK2, STAT4, IL6R) and augmented risk for seropositive RA [23].